The effects of 3-year growth hormone treatment and body composition in Polish patients with Silver-Russell syndrome.

Anna Świąder-Leśniak Dorota JurkiewiczHonorata KołodziejczykAgata KozłowskaAlicja KorpyszMieczysław Szalecki Krystyna H Chrzanowska

Published in: Endokrynologia Polska (2023)

Growth hormone therapy has a positive influence on the growth of SRS patients. Regardless of molecular abnormality type (11p15 LOM vs. upd(7)mat), height velocity was similar in SRS patients during 3 years of rhGH therapy.

Keyphrases

body composition
growth hormone
end stage renal disease
chronic kidney disease
ejection fraction
newly diagnosed
peritoneal dialysis
gold nanoparticles
resistance training
mesenchymal stem cells
stem cells
blood flow
physical activity
cell therapy